After a preliminary announcement a few weeks ago that included a CEO change, CVS Health CVS released its full third-quarter ...

Complete, End-to-End Patient Experience: With the addition of pharmacy capabilities, LifeMD now offers a fully integrated and cohesive experience, ensuring continuity of care at every stage — from ...

Third quarter net product revenues for ZORYVE® (roflumilast) franchise of $44.8M, with $22.0M for ZORYVE cream 0.3%, $20.3M for ZORYVE topical ...

VANCOUVER, BC / ACCESSWIRE / November 7, 2024 / Xebra Brands ('Xebra' or the 'Company') (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0), a leading player in the Mexican CBD industry, is pleased to announce the ...

Sigma has recently consolidated a number of regional warehouses but still has excess warehouse capacity. While this leaves significant space for growth without further investment, and it is the ...

These risks are described in the cautionary note regarding forward-looking statements, risk factors and management’s discussion and analysis ... increase of inventory stocking at specialty pharmacy ...

On Tuesday night, millions of Americans watched as former president Donald J. Trump gathered up enough electoral votes needed ...

Global health company The Cigna Group officials expect to participate in meetings with investors and analysts over the next several weeks. During these meetings, ...

Operator Welcome to SelectQuote's first-quarter earnings call. [Operator instructions] It is now my pleasure to introduce ...

The European Medicines Agency has approved Dupixent (dupilumab) to treat eosinophilic esophagitis (EoE) in children as young as one year of age. Specifically, the approval covers children aged one to ...

Rocket Pharmaceuticals, Inc. , a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today announced that ...

The European Medicines Agency has approved Dupixent as the first treatment for eosinophilic esophagitis (EoE) in young children aged one to 11, m ...